News

The latest round of MRFF grants will further drive innovation and research across Kids Research into areas such as childhood asthma, cancer, Cerebral Palsy and trauma care.

The groundbreaking FIREFLY-1 trial tested the efficacy of oral drug, tovorafenib, in brain tumour patients with results showing a 50 per cent tumour shrinkage in two thirds of patients.

OCD BOUNCE, an Australian-first paediatric public health service, is helping to bridge the gap and advance treatment for young people living with obsessive-compulsive disorder.

The two-day event hosted discussions by leading experts of not only the latest scientific developments in paediatric advanced therapeutics, but also their clinical counterparts.

The Children’s Hospital at Westmead has launched a world-first clinical trial investigating the use of phage therapy to treat a chronic bacterial infection in children with cystic fibrosis (CF).